The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. PTC Therapeutics Inc shares valued at $136,656 were sold by Klein Matthew B. on Apr 22 ’25. At $48.74 per share, Klein Matthew B. sold 2,804 shares. The insider’s holdings dropped to 273,234 shares worth approximately $11.62 million following the completion of this transaction.
Also, Klein Matthew B. purchased 2,804 shares, netting a total of over 136,656 in proceeds.
Before that, Golden Lee Scott had sold 897 shares from its account. In a trade valued at $42,114, the EVP & CHIEF MEDICAL OFFICER traded PTC Therapeutics Inc shares for $46.95 each. Upon closing the transaction, the insider’s holdings decreased to 897 shares, worth approximately $3.23 million.
As published in a research note from Citigroup on May 07, 2025, PTC Therapeutics Inc [PTCT] has been rated up from a Sell to a Neutral and the price target has been revised to $40. Analysts at BofA Securities upgraded the stock from ‘”an Underperform”‘ to ‘”a Neutral”‘ outlook in a report released in mid March. As of March 07, 2025, Scotiabank has initiated its “Sector perform” rating for PTCT. Earlier on December 13, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for PTCT stock which previously was a “an Equal-weight”.
Analyzing PTCT Stock Performance
During the last five days, there has been a drop of approximately -14.16%. Over the course of the year, PTC Therapeutics Inc shares have dropped approximately -5.83%. Shares of the company reached a 52-week high of $58.38 on 03/17/25 and a 52-week low of $35.95 on 05/06/25. A 50-day SMA is recorded $49.59, while a 200-day SMA reached $43.12.
Support And Resistance Levels for PTC Therapeutics Inc (PTCT)
According to the 24-hour chart, there is a support level at 40.28, which, if violated, would cause prices to drop to 38.06. In the upper region, resistance lies at 43.98. The next price resistance is at 45.46. RSI (Relative Strength Index) is 42.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.90, which suggests the price will decrease in the coming days. Percent R is at 55.22%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
